Singular Genomics Systems, Inc.

OMIC

Explore Our Financial Data > Companies > Singular Genomics Systems, Inc.

Identification

Click on a field for details on how to access that data via Web API, Excel, or CSV Download.

Ticker	OMIC
CIK	0001850906
SIC	3826
Sector	Manufacturing
Industry Category	Measuring And Control Equipment
Industry Group	Lab Analytical Instruments

Contact

Address	3010 SCIENCE PARK ROAD, SAN DIEGO, CA, 92121
Website	singulargenomics.com
Phone	(858) 333-7830
CEO	Andrew Spaventa
Employees	220

Access This Data

Our team will help you customize a package that meets the needs of your business.

Request a Consultation

Standardized Financials

docs

Intrinio provides professional-grade historical financial data. This data is standardized, cleansed and verified to ensure the highest quality data sourced directly from the XBRL financial statements. The primary purpose of standardized financials are to facilitate comparability across a single company’s fundamentals and across all companies fundamentals.

For example, it is possible to compare total revenues between two companies as of a certain point in time, or within a single company across multiple time periods. This is not possible using the as reported financial statements because of the inherent complexity of reporting standards.

Below is a preview of several data points from each financial statement, as well as a sample of our many calculated metrics:

Income Statement

Revenue	$2.67 million
Pre-Tax Income	$-86.32 million
Net Income	$-86.32 million
Net Income to Common	$-86.32 million
EPS	$-34.51

View All

Balance Sheet

Cash	$52.62 million
Assets	$186.55 million
Liabilities	$63.30 million
Common Equity	$123.25 million
Liabilities & Equity	$186.55 million

View All

Cash Flow Statement

Net Income	$-86.32 million
Cash From Operating Activities	$-80.43 million
Cash From Investing Activities	$98.49 million
Cash From Financing Activities	$152,000.00
Change in Cash	$18.21 million

View All

Calculations

NOPAT	$-65.10 million
EBITDA	$-88.33 million
Price to Earnings	N/A
Price to Book	$0.41
ROE	-53.57%

View All

Latest News

docs

Intrinio provides up-to-date news articles on every US company from various sources. Here are several examples:

Singular Highlights Key G4X™ Launch Milestones and Showcases Groundbreaking 3D Spatial Multiomic Performance at AGBT

SAN DIEGO, Feb. 24, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc., an innovator in high-throughput spatial multiomics technologies designed to advance precision medicine, today announced key development milestones for its G4X™ Spatial Sequencer at the Advances in Genome Biology and Technology (AGBT) conference in Marco Island, Florida. G4X Early Access Program Ongoing and Broader Availability on Track The G4X Early Access Program is currently underway at Beth Israel Deaconess Medical

Article Link

Singular Genomics Announces Closing of Acquisition by Deerfield Management

SAN DIEGO, Feb. 21, 2025 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, announced today the closing of its acquisition by an affiliate of Deerfield Management Company, L.P. On December 23, 2024, Singular Genomics announced that Deerfield had signed a definitive agreement to acquire all of the outstanding shares of Singular Genomics common sto

Article Link

Singular Genomics to be acquired by Deerfield for $20.00 per share in case

Singular Genomics (OMIC) Systems announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, will acquire Singular Genomics in an all-cash transaction for $20.00 per share. The $20.00 per share represents 254% premium to the last closing share price for Singular’s common stock prior to the September 12, 2024 public disclosure of Deerfield’s initial acquisition proposal. The Singular Genomics Board of Directors formed a special committee

Article Link

Singular Genomics Enters into Agreement to be Acquired by Deerfield for $20.00 in Cash per Share

SAN DIEGO, Dec. 23, 2024 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC) (“Singular Genomics” or the “Company”), a company leveraging novel next-generation sequencing (NGS) and spatial multiomics technologies to empower researchers and clinicians, today announced that it has entered into a definitive merger agreement whereby an affiliate of Deerfield Management Company, L.P. will acquire Singular Genomics in an all-cash transaction for $20.00 per share. The $20.00 per share re

Article Link

Similar Genomics Systems: Q3 Earnings Snapshot

SAN DIEGO (AP) — Singular Genomics Systems Inc. OMIC) on Tuesday reported a loss of $16.8 million in its third quarter. The San Diego-based company said it had a loss of $6.72 per share.

Article Link